Revive Therapeutics Data Access Plan Approved By The FDA; Partial Unblinded Data In Company Hands Jun 25, 2022
Cybin Announces Roster of 28 Expert Faculty and Advisors for its EMBARK Psychedelic Facilitator Training Program Jun 3, 2022
Trade To Black Podcast: Biomedical Engineer Analyzes Potential Phase 3 Outcomes For Revive Therapeutics COVID Trial May 29, 2022
Revive Therapeutics To Expedite Patient Enrollments For Phase 3 COVID Oral Therapeutic Trial Jan 5, 2022
Revive Therapeutics: Remains Discounted To Peers As Oral COVID Therapeutics Race Heats Up Aug 11, 2021
Cybin Launches EMBARK and Co-Sponsors First Clinical Trial to Treat Frontline Clinicians Experiencing COVID-Related… Jun 8, 2021
